Ad-ucation? Sorvinos plug Lantus in Sanofi web effort

Share this article:
Ad-ucation? Sorvinos plug Lantus in Sanofi web effort
Ad-ucation? Sorvinos plug Lantus in Sanofi web effort
Sanofi Aventis launched a Lantus-branded “diabetes awareness campaign" featuring Paul and Mira Sorvino.

The father-daughter acting duo, he of Goodfellas fame and she of Mighty Aphrodite, feature in the Diabetes Co-Stars campaign, talking about Paul's type 2 diabetes, diagnosed in 2006. A video-rich microsite housed alongside Lantus- and Apidra-branded content, includes a "Resources" tab featuring a pile of links where readers can “find more information about Lantus insulin, the Lantus SoloStar pen, and downloadable tools to help you monitor your blood sugar.” Sorvino takes Lantus.

In one of the clips, Mira Sorvino recalls a worrying spell of high blood sugar her father suffered shortly after his diagnosis.

“So, at that point I realized that I, I needed to be a, uh, a better support to him and figure out what I could do to help him manage his blood sugars better and find out more about the disease,” says Sorvino. “I did speak with a doctor, I spoke with some experts, I had a friend who has diabetes…and I did some reading on the web. So, it's sort of a combination of informed sources, to help me understand it.”

“The information is there,” says her father. “You talk to professionals. A lot of it's on the web all you have to do is punch that up and visit those sites and you need to learn what it is that's happened to you.”

The site was executed by Euro RSCG Life 4D.

Share this article:

Email Newsletters

More in News

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.

GSK second-quarter sales disappoint

GSK second-quarter sales disappoint

Executives urge analysts to focus on the company's long-term potential.

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union